On Monday, Ardelyx Inc (NASDAQ: ARDX) opened higher 2.25% from the last session, before settling in for the closing price of $5.77. Price fluctuations for ARDX have ranged from $3.43 to $10.13 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales growth of Healthcare Sector giant was 146.90%. Company’s average yearly earnings per share was noted 14.10% at the time writing. With a float of $226.74 million, this company’s outstanding shares have now reached $232.45 million.
Let’s determine the extent of company efficiency that accounts for 267 employees. In terms of profitability, gross margin is 85.86%, operating margin of -28.05%, and the pretax margin is -30.68%.
Ardelyx Inc (ARDX) Breakdown of a Key Holders of the stock
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Ardelyx Inc is 3.69%, while institutional ownership is 62.21%. The most recent insider transaction that took place on Oct 28 ’24, was worth 147,740. Before that another transaction happened on Oct 11 ’24, when Company’s President & CEO sold 7,500 for $6.01, making the entire transaction worth $45,075. This insider now owns 1,210,108 shares in total.
Ardelyx Inc (ARDX) Recent Fiscal highlights
If we go through the results of last quarter, which was made public on 6/30/2024, the company posted 0.03 earnings per share (EPS) for the quarter, besting the agreed prediction (set at -0.11) by 0.14. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.03 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 14.10% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 30.00% during the next five years compared to 28.61% growth over the previous five years of trading.
Ardelyx Inc (NASDAQ: ARDX) Trading Performance Indicators
Check out the current performance indicators for Ardelyx Inc (ARDX). In the past quarter, the stock posted a quick ratio of 3.99. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 6.61.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.28, a number that is poised to hit -0.05 in the next quarter and is forecasted to reach -0.07 in one year’s time.
Technical Analysis of Ardelyx Inc (ARDX)
Looking closely at Ardelyx Inc (NASDAQ: ARDX), its last 5-days average volume was 2.45 million, which is a drop from its year-to-date volume of 4.86 million. As of the previous 9 days, the stock’s Stochastic %D was 58.97%. Additionally, its Average True Range was 0.27.
During the past 100 days, Ardelyx Inc’s (ARDX) raw stochastic average was set at 27.76%, which indicates a significant decrease from 63.64% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 33.57% in the past 14 days, which was lower than the 81.16% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $6.08, while its 200-day Moving Average is $7.02. However, in the short run, Ardelyx Inc’s stock first resistance to watch stands at $6.00. Second resistance stands at $6.10. The third major resistance level sits at $6.20. If the price goes on to break the first support level at $5.80, it is likely to go to the next support level at $5.70. Now, if the price goes above the second support level, the third support stands at $5.60.
Ardelyx Inc (NASDAQ: ARDX) Key Stats
There are currently 232,700K shares outstanding in the company with a market cap of 1.39 billion. Presently, the company’s annual sales total 124,460 K according to its annual income of -66,070 K. Last quarter, the company’s sales amounted to 73,220 K and its income totaled -16,450 K.
